All sites C00-96,D32-33,D42-43,D45-47,D76 791 91.8 1.5 3.0 1.1 2.6
Mouth, pharynx C00-14 17 100.0 - - - -
  Lip C00 3 100.0 - - - -
  Tongue C02 4 100.0 - - - -
  Mouth, other C03-06 3 100.0 - - - -
  Salivary glands C07-08 1 100.0 - - - -
  Pharynx C01,C09-14 6 100.0 - - - -
Digestive organs C15-26 156 89.6 1.3 4.4 1.4 3.3
  Oesophagus C15 9 95.7 - - 4.3 -
  Stomach C16 21 95.2 1.0 1.9 - 1.9
  Small intestine C17 4 90.5 - - - 9.5
  Colon C18 40 97.0 - 0.5 0.5 2.0
  Rectum, rectosigmoid C19-20 30 98.0 - 1.3 - 0.7
  Anus C21 1 100.0 - - - -
  Liver C22 15 86.3 1.4 9.6 1.4 1.4
  Gallbladder, bile ducts C23-24 7 80.0 2.9 8.6 2.9 5.7
  Pancreas C25 24 68.9 4.2 16.0 4.2 6.7
  Other digestive organs C26 4 57.1 9.5 - 4.8 28.6
Respiratory organs C30-39 92 76.6 6.8 9.0 2.8 4.8
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 6 100.0 - - - -
  Lung, trachea C33-34 84 74.8 7.4 9.7 3.1 5.0
  Mediastinum, pleura C38 - - - - - -
Bone C40-41 2 100.0 - - - -
Melanoma of the skin C43 27 100.0 - - - -
Skin, non-melanoma C44 36 98.9 - 1.1 - -
Mesothelioma C45 4 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 5 96.0 - - - 4.0
Breast C50 1 100.0 - - - -
Male genital organs C60-63 278 99.3 - 0.1 0.4 0.1
  Prostate C61 270 99.3 - 0.1 0.4 0.1
  Testis C62 6 100.0 - - - -
  Other male genital C60,C63 2 100.0 - - - -
Urinary organs C64-68 69 95.1 0.3 2.9 0.6 1.2
  Kidney C64 23 88.0 - 6.8 1.7 3.4
  Bladder and urinary tract2 C65-68 46 98.7 0.4 0.9 - -
Eye C69 1 60.0 - 40.0 - -
Brain, central nervous system C70-72,D32-33,D42-43 20 81.8 - 11.1 3.0 4.0
Thyroid gland C73 6 100.0 - - - -
Other endocrine glands C74-75 1 100.0 - - - -
Illdefined or unknown C76,C80 15 64.0 8.0 13.3 5.3 9.3
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 63 80.6 4.1 2.5 1.6 11.1
  Hodgkin lymphoma C81 2 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 29 99.3 - - - 0.7
  Malignant immunoproliferative diseases C88 0 100.0 - - - -
  Myeloma and other plasma cell tumors C90 9 62.2 4.4 15.6 6.7 11.1
  Leukaemia C91-95 15 78.4 8.1 1.4 - 12.2
  Myelodysplastic syndromes D46 5 15.4 19.2 - 7.7 57.7
  Myeloproliferaitive neoplasms D45,D47 2 50.0 - - - 50.0
Not included above
  Basal cell carcinoma of the skin 111 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.